Vixi Biotech is disrupting the liver diagnostics market by commercializing an innovative blood test for diagnosing common liver diseases such as non-alcoholic steatohepatitis (NASH). Our flagship product, AccuNash™, is intended to be a low-cost, simple way to inform physicians on the severity of liver disease in broad populations worldwide. The goal is to easily and quickly characterize patients with liver disease using a standard blood sample. Vixi intends to offer a better alternative to existing methods, such as biopsy procedures, which are invasive, risky, expensive, and painful.
Company Details
- Founded
- -
- Address
- 104 Faculty St, Blacksburg,virginia 24060,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://vixibiotech.com
- HQ
- Blacksburg, Virginia
- Competitors
- Radian Health.
Vixi Biotech Questions
Vixi Biotech's website is http://vixibiotech.com
Vixi Biotech's LinkedIn profile is https://www.linkedin.com/company/vixibiotech
Vixi Biotech's industry is
Biotechnology Research
Vixi Biotech's top competitors are
Radian Health.
Vixi Biotech's categories are Biotechnology Research
Vixi Biotech's founding year is 2017
